Wei-Ting Hsu

Title: Innovations by Wei-Ting Hsu

Introduction

Wei-Ting Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 6 patents, Hsu's work focuses on developing novel therapeutic approaches for cancer treatment.

Latest Patents

Hsu's latest patents include groundbreaking inventions such as the Anti-carbonic anhydrase IX antibody. This invention relates to epitopes located in CAIX and anti-CAIX antibodies that exhibit binding activity with cancer cells. The invention also encompasses the composition and application of CAIX epitopes and anti-CAIX antibodies in the diagnosis, prevention, and treatment of cancers. Another notable patent is his work on Personalized cancer immunotherapy. This disclosure outlines a method for obtaining an antibody or antigen-binding fragment that specifically binds to a tumor sample. The process involves administering autologous dendritic cells to a subject, taking immune cells and a tumor sample, constructing an antibody library, and screening it to obtain the specific antibody. This method also includes engineering immune cells and antibodies for targeted cancer treatment.

Career Highlights

Wei-Ting Hsu has worked with notable companies such as Lite-On Technology Corporation and Navi Bio-Therapeutics, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and cancer research.

Collaborations

Hsu has collaborated with esteemed colleagues, including Bor-Yu Tsai and Shin-Tsung Huang. These partnerships have further enhanced his research and development efforts in cancer therapies.

Conclusion

Wei-Ting Hsu's innovative work in cancer research and his impressive portfolio of patents highlight his significant contributions to the field. His dedication to developing effective cancer treatments continues to inspire advancements in medical science.